A Study on the Pharmacokinetic/Pharmacodynamic Profiles of the Novel PPAR Pan Agonist Chiglitazar Sodium in Rats with Hypoalbuminemia
Wenjuan He, Xinhui Zhang, Menghao Li, Bokun Chen, Yunfei Tian, Qian Sun, Xiaojuan Zhao, Yonghong Zhao, Dan Xiao Li, Xiuju Liu
This study compares the PK/PD profiles of Chiglitazar Sodium in healthy rats and those with hypoalbuminemia, finding no significant differences except for Tmax.
Journal of Clinical Pharmacy and Therapeutics · Jan 1, 2026Peer-reviewedPharmacology & Toxicology